[1] |
Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu.
Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
|
[2] |
Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong.
Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896.
|
[3] |
Du Yuhua, Feng Yajuan, Lei Yu, Lai Keng, He Weiyun.
Analysis of the detection and treatment of rifampicin-resistant pulmonary tuberculosis patients in Guangzhou during the “12th Five-Year Plan” and “13th Five-Year Plan” periods
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 678-686.
|
[4] |
Ge Jing, Wang Jun, He Yuqi, Nie Wenjuan.
Six cases of pseudomembranous colitis caused by anti-tuberculosis drugs and literature review
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1320-1326.
|
[5] |
CAO Pan, LIANG Kuang-li, YUAN Ji-xin, LI Yong-bo, CHEN Rui, ZHANG Zhi-fei, WU Qian-hong.
Analysis of CT findings in patients with initial and retreated cavernous rifampicin-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(7): 694-701.
|
[6] |
RUAN Yun-zhou, SU Wei, JIANG Jia-wen, LI Ren-zhong.
The effect of case finding of pulmonary tuberculosis and rifampicin resistance tuberculosis with GeneXpert MTB/RIF test in economic undeveloped areas
[J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1275-1279.
|
[7] |
WANG Meng, WAN Yi-you, XIE Tian, LI Jian-hua, RUAN Yun-zhou, LIU Yue-yuan, HU Jia, FENG De-an, GUO Hui-ying, LI Ren-zhong.
Analysis of the epidemiological characteristics of rifampicin-resistant pulmonary tuberculosis in Ganzhou, Jiangxi from 2019 to 2020
[J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1287-1291.
|
[8] |
FANG Mu-tong, SU You-feng, MAO Zhi, ZHANG Hong-yi, ZENG Jian-feng, ZENG Jian, CAO Wei-peng, WANG Zhong-yuan.
Analysis of phenotypic drug sensitivity test of rifampicin-resistant Mycobacterium tuberculosis by GeneXpert MTB/RIF
[J]. Chinese Journal of Antituberculosis, 2021, 43(11): 1159-1163.
|
[9] |
LUO Hui, RUAN Yun-zhou, ZHAO A-li, YUAN Rong, HE Xiao-mou, LI Ren-zhong.
Analysis of the effect of patients care on the level of sputum specimens submitted for examination among outpatient follow-up of rifampicin-resistant pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2021, 43(10): 1046-1051.
|
[10] |
LIU Er-yong, ZHOU Lin, XUE Xiao, LIU Chun-fa, BAI Li-qiong, LU Wei, ZHANG Tian-hua, CHENG Shi-ming.
Evaluation of treatment effect and safety of rifampicin capsule (Ⅱ) on pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1092-1099.
|
[11] |
Yuan LIU,Jun ZHOU,Xiao-li CUI,Jia-yuan LEI,Guo-lian ZHAO,Li-yun DANG.
The relationship between false-positive rifampicin resistant results of GeneXpert MTB/RIF and very low bacterial load in the clinical samples
[J]. Chinese Journal of Antituberculosis, 2019, 41(2): 176-180.
|
[12] |
GUO Shao-chen,ZHU Hui,XU Jian,HAO Lan-hu,WANG Bin, FU Lei,CHEN Ming-ting,ZHOU Lin,CHI Jun-ying, LU Yu.
Study on pharmacokinetics and bioequivalence of rifampicin in fixed-dose combination
[J]. Chinese Journal of Antituberculosis, 2014, 36(12): 1075-1079.
|
[13] |
JIN Hai-xia, FU Lei, WANG Bin, ZHENG Mei-qin, LU Yu.
Study on the rifampicin-dependent characteristics of Mycobacterium tuberculosis clinical isolate
[J]. Chinese Journal of Antituberculosis, 2012, 34(10): 670-675.
|
[14] |
Yang Caie,Wang Yan,Lei Hong,Sun Bin,Meng Xianghong,Dong Mei.
Comparative analysis on the anti-tuberculosis drug resistance of the rifampin-dependent and -resistant strains of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2011, 33(3): 163-165.
|
[15] |
ZHANG Jun-xian, WU Xue-qiong, YANG You-rong, LIANG Yan.
[J]. Chinese Journal of Antituberculosis, 2011, 33(10): 680-685.
|